Annäherung an die soziale Wirklichkeit der SS-Ärzte. Sprachanalysen und sozialpsychologische Untersuchungen anhand von Hans Münchs Erinnerungserzählungen

Die Arbeit untersucht, wie Tätererinnerungen für die Geschichtswissenschaft nutzbar gemacht werden können. Hans Münch, ein ehemaliger SS-Arzt in Auschwitz, hat sein Leben lang zahlreiche Interviews gegeben. Diese werden einer Sprach- und Diskursanalyse unterzogen und aus sozialpsychologischer Perspektive betrachtet. Dabei wird deutlich, wie die Methodenwahl die Ergebnisse mitbestimmt. Strukturelemente und Rahmenbedingungen, die das Denken und Handeln Münchs beeinflusst haben, werden herausgearbeitet. Dadurch werden die soziale Wirklichkeit der SS-Ärzte sowie die Beweggründe für diesen Genozid auf der Täterebene greifbarer gemacht. Es wird aufgezeigt, wie Münch Brüche in seiner Lebensgeschichte mit einem konsistenten Selbstbild, einer Sinnkonstruktion, zu überdecken versuchte.

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.

Biologic agents (also termed biologicals or biologics) are therapeutics that are synthesized by living organisms and directed against a specific determinant, for example, a cytokine or receptor. In inflammatory and autoimmune diseases, biologicals have revolutionized the treatment of several immune-mediated disorders. Biologicals have also been tested in allergic disorders. These include agents targeting IgE; T helper 2 (Th2)-type and Th2-promoting cytokines, including interleukin-4 (IL-4), IL-5, IL-9, IL-13, IL-31, and thymic stromal lymphopoietin (TSLP); pro-inflammatory cytokines, such as IL-1β, IL-12, IL-17A, IL-17F, IL-23, and tumor necrosis factor (TNF); chemokine receptor CCR4; and lymphocyte surface and adhesion molecules, including CD2, CD11a, CD20, CD25, CD52, and OX40 ligand. In this task force paper of the Interest Group on Biologicals of the European Academy of Allergy and Clinical Immunology, we review biologicals that are currently available or tested for the use in various allergic and urticarial pathologies, by providing an overview on their state of development, area of use, adverse events, and future research directions.

Mobility and Bandwidth Prediction as a Service in Virtualized LTE Systems

Recently telecommunication industry benefits from infrastructure sharing, one of the most fundamental enablers of cloud computing, leading to emergence of the Mobile Virtual Network Operator (MVNO) concept. The most momentous intents by this approach are the support of on-demand provisioning and elasticity of virtualized mobile network components, based on data traffic load. To realize it, during operation and management procedures, the virtualized services need be triggered in order to scale-up/down or scale-out/in an instance. In this paper we propose an architecture called MOBaaS (Mobility and Bandwidth Availability Prediction as a Service), comprising two algorithms in order to predict user(s) mobility and network link bandwidth availability, that can be implemented in cloud based mobile network structure and can be used as a support service by any other virtualized mobile network services. MOBaaS can provide prediction information in order to generate required triggers for on-demand deploying, provisioning, disposing of virtualized network components. This information can be used for self-adaptation procedures and optimal network function configuration during run-time operation, as well. Through the preliminary experiments with the prototype implementation on the OpenStack platform, we evaluated and confirmed the feasibility and the effectiveness of the prediction algorithms and the proposed architecture.